Document Detail

Ceramide in stem cell differentiation and embryo development: novel functions of a topological cell-signaling lipid and the concept of ceramide compartments.
Jump to Full Text
MedLine Citation:
PMID:  21490805     Owner:  NLM     Status:  PubMed-not-MEDLINE    
In the last two decades, the view on the function of ceramide as a sole metabolic precursor for other sphingolipids has completely changed. A plethora of studies has shown that ceramide is an important lipid cell-signaling factor regulating apoptosis in a variety of cell types. With the advent of new stem cell technologies and knockout mice for specific steps in ceramide biosynthesis, this view is about to change again. Recent studies suggest that ceramide is a critical cell-signaling factor for stem cell differentiation and cell polarity, two processes at the core of embryo development. This paper discusses studies on ceramide using in vitro differentiated stem cells, embryo cultures, and knockout mice with the goal of linking specific developmental stages to exciting and novel functions of this lipid. Particular attention is devoted to the concept of ceramide as a topological cell-signaling lipid: a lipid that forms distinct structures (membrane domains and vesicles termed "sphingosome"), which confines ceramide-induced cell signaling pathways to localized and even polarized compartments.
Erhard Bieberich
Related Documents :
2531185 - Ige receptor on human eosinophils (fcerii). comparison with b cell cd23 and association...
19321355 - Polyamine metabolism during the cell cycle of synchronized tobacco by-2 cell line.
2501315 - Heparin stimulation of plasminogen activator secretion by macrophage-like cell line raw...
25424385 - High-density self-contained microfluidic koala kits for use by everyone.
12065945 - Non-invasive fetal sex determination on fetal erythroblasts from the maternal circulati...
7251225 - Transformed and neoplastic phenotype: reversibility during culture by cell density and ...
Publication Detail:
Type:  Journal Article     Date:  2010-12-29
Journal Detail:
Title:  Journal of lipids     Volume:  2011     ISSN:  2090-3049     ISO Abbreviation:  J Lipids     Publication Date:  2011  
Date Detail:
Created Date:  2011-04-14     Completed Date:  2011-07-14     Revised Date:  2014-09-10    
Medline Journal Info:
Nlm Unique ID:  101553819     Medline TA:  J Lipids     Country:  Egypt    
Other Details:
Languages:  eng     Pagination:  610306     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Grant Support

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): J Lipids
Journal ID (publisher-id): JL
ISSN: 2090-3030
ISSN: 2090-3049
Publisher: Hindawi Publishing Corporation
Article Information
Download PDF
Copyright © 2011 Erhard Bieberich.
Received Day: 26 Month: 7 Year: 2010
Accepted Day: 29 Month: 11 Year: 2010
Print publication date: Year: 2011
Electronic publication date: Day: 29 Month: 12 Year: 2010
Volume: 2011E-location ID: 610306
ID: 3066852
PubMed Id: 21490805
DOI: 10.1155/2011/610306

Ceramide in Stem Cell Differentiation and Embryo Development: Novel Functions of a Topological Cell-Signaling Lipid and the Concept of Ceramide Compartments
Erhard BieberichI1*
Program in Developmental Neurobiology, Institute of Molecular Medicine and Genetics, School of Medicine, Medical College of Georgia, 1120 15th Street Room CA4012, Augusta, GA 30912, USA
Correspondence: *Erhard Bieberich:
[other] Academic Editor: Walter M. Holleran

1. Ceramide: Taming of the Sphinx

When the “father of neurochemistry”, the German pathologist Johann Ludwig Wilhelm Thudichum (1829–1901), coined the term sphingolipids at the end of the 19th century, he must have thought of the Sphinx, a mythological creature testing human wit by asking riddles (which ended deadly if not answered correctly). Indeed, defining the cell-signaling function of the sphingolipid ceramide is like trying to solve a riddle posed by the Sphinx (without the grim ending, hopefully). The discovery that ceramide has a cell-signaling function goes back by more than 20 years. Interestingly, the first studies on ceramide elevation by serum deprivation or vitamin D incubation rather focused on the role of ceramide in cell cycle arrest and differentiation [13]. It was a few years later that ceramide emerged as one of the key factors inducing apoptosis [46].

Since then, several thousand publications have focused on ceramide-inducing apoptosis, while much fewer studies were concerned with other functions of ceramide. This was mainly due to the limited availability of genetic approaches to alter ceramide metabolism and the rather broad group specificity of ceramide analogs and biosynthesis inhibitors. In particular, studies in Dr. Alfred Merrill's laboratory have shown that although inhibitors such as myriocin (serine palmitoyl transferase) and fumonisin B1 (ceramide synthases) are specific for their target enzymes, the inhibitory effect leads to the depletion of many ceramide species and derivatives [712]. Moreover, inhibiting ceramide synthase with fumonisin B1 can also result in the elevation of sphingosine (dihydrosphingosine), which itself can be toxic for various cell types. Therefore, loss-of-function experiments using these inhibitors do not accurately pinpoint which sphingolipid is instrumental in apoptosis (or other biological effects). On the other hand, gain-of-function experiments using ceramide analogs are troubled by the low water solubility of compounds whose structure comes close to that of natural ceramide (C16–C24 ceramide). In addition, water-soluble short-chain ceramides such as C6 or C8 ceramide can be recycled and converted to long chain ceramides [1315]. Therefore, biological effects lost or regained could have been attributed to various ceramide species and derivatives. However, a particular combination of ceramide biosynthesis/metabolism inhibitors and ceramide or ceramide analogs successfully demonstrated the cell-signaling function of ceramide. When cells are preincubated with the ceramide synthase inhibitor fumonisin B1, addition of distinct ceramide species or ceramide analogs can restore the ceramide-related phenotype. Because de novo biosynthesis as well as the recycling pathway is inhibited, exogenously added ceramide is not converted to other ceramide species (although degradation and conversion to ceramide derivatives is still possible). Exceptionally powerful is the combination of myriocin or fumonisin B1 with ceramide analogs that are not convertible to other sphingolipids. Using this combination of reagents, our laboratory has shown for the first time that specific ceramide species are vital for the formation and differentiation of embryonic epithelia [16, 17].

2. Differentiating Stem Cells and the Bright Side of Ceramide

Embryonic stem (ES) cells in vitro differentiated to neural cell types undergo phenotypical changes that recapitulate embryo development. In the first differentiation step called germ layer formation, nonpolarized stem cells form embryoid bodies that are composed of a two-layer sphere: an outer primitive endoderm and an inner primitive ectoderm layer [16]. Since the primitive ectoderm is the primordial epithelium for all embryonic tissues, embryoid bodies are a bona fide in vitro model for the acquisition of germ layer cell polarity. Apicobasal cell polarity of primitive ectoderm cells is crucial for the organization and morphogenesis of the three embryonic germ layers: endoderm, mesoderm, and ectoderm. When embryoid bodies were depleted of ceramide by the incubation with myriocin or fumonisin B1, they did not form a primitive ectoderm layer. Instead, massive apoptosis of cells within the embryoid bodies was observed [16]. Supplementation of the culture medium with C16 ceramide or the novel ceramide analog N-oleoyl serinol (S18) prevented apoptosis and restored primitive ectoderm formation (Figure 1 for structures). These intriguing results were the first experimental evidence that ceramide was functionally involved in the regulation of embryonic cell polarity.

S18 is a special kind of ceramide analog designed and synthesized in our laboratory [18, 19]. By maintaining the polar (serine-derived) head group of ceramide, and at the same time, enhancing the water solubility of the lipophilic portion, we obtained a water-soluble, but still lipophilic, structural analog of ceramide (Figure 1). The extensive characterization of S18 showed that it incorporates into cell membranes and activates atypical PKC (aPKC), which was also found for ceramide [1821]. Moreover, ceramide and S18 induce the formation of aPKC-associated complexes with polarity proteins such as Par6 and the small Rho-type GTPase Cdc42 (Figures 2(a) and 2(b)). This was shown using in vitro complementation assays with ceramide vesicles and purified proteins, but also in living cells visualizing S18-induced polarity protein complexes by immunocytochemistry [16, 17, 2022]. Most excitingly, by developing a highly specific antibody against ceramide, we could show that the S18-induced protein complexes were identical to those associated with ceramide [16, 17, 23]. Therefore, our studies explained for the first time how ceramide can organize cell polarity on the molecular level.

Primitive ectoderm cells encompassing the lumen of the embryoid body are polarized similar to cells in the primitive ectoderm layer of the preimplantation embryo. The apical cell membrane facing the lumen or the pro-amniotic cavity is associated with F-actin and interconnected to adjacent cells via β-catenin. Using the anticeramide antibody, we found that in primitive ectoderm cells of embryoid bodies, the apical membrane was tremendously enriched in ceramide and codistributed with aPKC, Cdc42, F-actin, and β-catenin [16]. The apical membrane of the preimplantation embryo was also enriched in ceramide and codistributed with F-actin. Taken together, these results led us to design a model for ceramide-induced cell polarity. In this model, apical ceramide recruits aPKC to the membrane and organizes a cell polarity complex with Par6 and Cdc42, thereby stabilizing β-catenin and F-actin [22]. This was the first model combining the topological/structural properties of ceramide with a cell-signaling pathway regulating cell polarity (Figure 2(b)).

Cell polarity complexes associated with aPKC are not only involved in the acquisition of apicobasal polarity, but also in other cell-polarity-related processes such as cell adhesion and migration. Therefore, we tested if the function of ceramide can be extended to other aspects of aPKC-controlled cell polarity. So far, we have found that ceramide is critical for cell migration of neural progenitors, cell adhesion of epithelia, and ciliogenesis [16, 21, 22, 24]. The function of ceramide in these processes will be discussed in the following sections.

3. Cells on the Rest Getting Ready to Move: New Par-Tners Court for Ceramide

From the very beginning, ceramide was found to be elevated in resting cells. As a typical response to serum deprivation/withdrawal, cells go into G0 cell cycle arrest concurrent with hydrolysis of sphingomyelin to ceramide [1, 3]. Recently, it has been shown that the elevation of ceramide in serum-deprived cells activates protein phosphatase 2a (PP2a) which then activates histone deacetylase (HDAC) and downregulates telomerase, an enzyme critical for cell cycle progression [25]. Our laboratory was interested in finding out which other properties of nonproliferating cells are regulated by ceramide. Madin Darby Canine Kidney (MDCK) cells are an exquisite in vitro model to study the dynamics of cell adhesion, polarity, and ciliogenesis in resting cells. MDCK cells are rapidly dividing until they reach confluence. They establish firm adhesion junctions and eventually develop a primary cilium. This cilium only appears in G0-arrested cells and disappears when cells re-enter the cell cycle. Therefore, we used confluent and serum-deprived MDCK cells to study the function of ceramide in cell adhesion and ciliogenesis. Based on our results with embryonic epithelia, we focused on the effect of ceramide on aPKC, a key factor in the assembly of polarity complexes that are critical for cell adhesion and ciliogenesis.

The role of ceramide binding to aPKC was determined by first generating a dominant negative mutant of aPKC (C20ζ-GFP), which binds ceramide but does not associate with or phosphorylate client proteins involved in cell polarity [22] (Figure 2(a)). Based on the results of binding assays using proteolytic fragments of aPKC, we narrowed down the ceramide binding site to amino acid 405–592 in the C-terminal moiety of the enzyme. This portion of aPKC does not bind to the polarity protein Par6 and does not encompass the kinase domain. Binding of ceramide to the C-terminus of aPKC was very surprising since the C1 domain (amino acid 131–180) in the regulatory portion of the enzyme was previously suggested to bind to ceramide [26, 27] (Figure 2(a)). Most recently, the C1 domain of a related protein has been found to bind to ceramide [28]. Therefore, it is likely that aPKC has two ceramide-binding sites, one in the C1 domain and another one in the C-terminus. However, based on our results, we conclude that binding to the C-terminal portion was sufficient to compete with endogenous aPKC for ceramide. We tested the effect of the dominant negative mutant using immunocytochemistry for adherens junction proteins and by monitoring transepithelial resistance [21]. Expression of the dominant-negative mutant in confluent MDCK cells compromised adherens junctions and epithelial cell contacts by affecting the intracellular distribution and protein levels of E-cadherin and β-catenin. The two proteins were no longer distributed to the adherens junctions, where they participate in a larger protein complex with aPKC. Since this adherens junction complex is regulated by the association of aPKC with Par6 and Cdc42, it is likely that the dominant negative mutant competed with endogenous aPKC for binding to ceramide, but it was not associated with other proteins required to form the junction complex. Consistently, depleting MDCK cells of ceramide with fumonisin B1 also impaired transepithelial resistance, which was restored by the addition of S18 or C16 ceramide [21]. Based on these results, it is reasonable to hypothesize that the ceramide-aPKC interaction is a vital part of the entry reaction in the formation of adherens junctions in epithelial cells.

In the ventricular neuroepithelium of mouse embryonic brain, neural progenitors divide asymmetrically with one daughter cell staying attached to the epithelium, while the other daughter cell migrates toward the cortical layer and eventually undergoes neural differentiation. Interestingly, aPKC is critical for two apparently opposite processes related to cell polarity: cell adhesion of neural progenitors in the neuroepithelium and migration of neural progenitors away from it. We tested if the ceramide-aPKC interaction was also important for these cell-polarity-related processes in the neuroepithelium. A reliable in vitro assay to test the effect of a compound on motility and migration is the wounding or scratch migration assay. Cells will be grown to confluence, a gap prepared by scraping off cells, and the velocity will be determined by which cells migrate into the gap. Our results showed that depleting neural progenitors of ceramide using myriocin significantly slowed down cell migration [17]. Migration was restored by supplementing the medium with S18 or C16 and C18:1 ceramide. We used C18:1 ceramide because it was one of the major ceramide species found in neural progenitors (in contrast to C18 ceramide, the monounsaturated C18:1 ceramide is a minor species in adult brain [29]). The typical short-chain ceramide analogs used for induction of apoptosis such as C2 or C8 ceramide did not induce or restore migration. This was the first evidence that distinct ceramide species are required for aPKC-related cell polarity. In conjunction with the previous results on apicobasal polarity of primitive ectoderm cells and cell adhesion of MDCK cells, one may speculate that C16 ceramide is more important for polarity and adhesion of nonmotile cells, while C18:1 ceramide is more involved in cell migration.

With the advent of knockout mice for specific ceramide synthases, the focus of the ceramide field has switched from the more generalized effect of ceramide depletion or supplementation to a distinct ceramide composition. In this regard, the ceramide synthase 2 (CerS2 or lass2) knockout mouse shows a remarkable phenotype. Knockout of CerS2 results in hepatocarcinomas and myelin defects eventually leading to death of mice within two years after birth [3032]. The complete depletion of very long-chain ceramides (C22 and C24 ceramide) in liver and brain is consistent with the substrate specificity of CerS2 for the respective acyl CoA. However, the total ceramide levels are not different from those of the wild type because loss of very long-chain ceramides is compensated by the elevation of C16 and C20 ceramide. Moreover, CerS2 knockout mice also show elevation of phospholipids such as phosphatidylethanolamine with C18:1 and C18:2 fatty acids [31]. The authors of the CerS2 knockout study found that these changes increase the membrane fluidity, which was due to the compensatory changes in the lipid composition of the mouse. It should be mentioned that these mice are devoid of C24:1 ceramide, a very long-chain ceramide that is a major species in the cell membrane and known to increase membrane fluidity because of its nonsaturation. With respect to migration of neural progenitors, it is reasonable to speculate that the exquisite properties of C18:1 ceramide to enhance migration may be due to similar effects on membrane fluidity. It is noteworthy that similar effects of nonsaturated ceramide on enhancing membrane fluidity have also been shown for cold adaptation of plants, suggesting that membrane fluidity is a parameter critically regulated by ceramide in a vast variety of organisms [33]. It will be part of our future research to determine if specific changes in the ceramide composition of the cell membrane are correlated with distinct functions during neural progenitor differentiation.

4. Apoptosis as Polarity Disorder: When Atypical PARtners Akt up on Bad

While the previous sections were focused on the beneficial roles of ceramide in cell adhesion and migration, cell polarity of neural progenitors may also be disturbed by proapoptotic proteins competing with polarity proteins for binding to ceramide-associated aPKC. Apoptosis of neural progenitors may thus be a polarity disorder on the cellular and molecular level. We found that prostate apoptosis response 4 (PAR-4, not related to Par6), a pro-apoptotic protein first described in prostate cancer cells, sensitizes neural progenitors to ceramide-induced apoptosis [20, 22, 3438]. Using in vitro complementation assays with ceramide vesicles, coimmunoprecipitation assays, and immunocytochemistry using an antibody against ceramide developed in our laboratory, we found for the first time that ceramide induces binding of aPKC to PAR-4 [20, 23, 35, 36]. This was consistent with similar findings in other cell types showing that binding of PAR-4 inhibits aPKC [39, 40]. In conjunction with our studies on ceramide-induced association of Par6-Cdc42 with aPKC, it is reasonable to speculate that PAR-4 and Par6-Cdc42 compete for binding to ceramide-associated aPKC (Figure 2(b)).

In cells with low PAR-4 expression (or inactive PAR-4), ceramide-associated aPKC nucleates a polarity protein complex by binding to Par6 and Cdc42. This will either stabilize cell adhesion (via E-cadherin and β-catenin) or induce migration (via inactivation of GSK-3β; see [17, 21] for details) (Figure 2(b)). The regulation of the balance between cell adhesion and migration involving a similar aPKC-associated protein complex is still enigmatic. It may very well be controlled by binding of aPKC to membrane lipids such as distinct ceramide or phosphatidylinositol phosphate (PIP) species, which recruit and stabilize different protein scaffolds associated with aPKC (Figure 3(a)) [22]. On the other hand, if PAR-4 expression is high (or PAR-4 is activated), the ceramide-aPKC lipid-protein complex will be inhibited by PAR-4 (Figure 2(b)).

In differentiating ES cells, we have found that this mechanism can eliminate unwanted tumorigenic stem cells. When embryoid bodies are plated on tissue culture dishes, the attached cells undergo neural differentiation in the absence of serum and the presence of fibroblast growth factor 2 (FGF-2). Interestingly, there is an enormous rate of cell death in the first 48 h of cultivation diminishing about half of the culture. The apoptotic cells show high expression level of Oct-4, a marker for pluripotency typical for primitive ectoderm cells, and PAR-4, the sensitizer for ceramide-inducible apoptosis [34, 35, 37]. We confirmed the critical role of PAR-4 for apoptosis by knocking-down this protein, which resulted in survival of the Oct-4-expressing cells. Moreover, supplementation of the medium with the ceramide analog S18 eliminated Oct-4/PAR-4 coexpressing stem cells [37]. This result was very exciting and significant because stem cells that retain Oct-4 expression formed tumors (teratoma) instead of differentiating and integrating into the host tissue. Elimination of these tumor stem cells by S18 is a major step in enhancing the safety of stem cell transplantation.

It should be noted that another group has followed up on our studies by administering liposomal ceramide to undifferentiated human ES cells [41]. This group found that ceramide can maintain the undifferentiated state by eliminating prematurely differentiated cells. On first sight, this may be contradictory to our results in that we reported the elimination of residual pluripotent stem cells by ceramide. However, residual pluripotent stem cells are not identical to undifferentiated cells because they are derived from primitive ectoderm in embryoid bodies. These cells are, similar to prematurely differentiated stem cells, dysfunctional in that they deviate from the normal path of differentiation. We have termed these cells “Zombie cells” because they remain “undead” and form tumors unless they are eliminated by the administration of ceramide analogs [37]. It should also be noted that the precise role of ceramide in stem cell differentiation is still unclear. While our studies and those from other laboratories show that ceramide eliminates improperly differentiating stem cells, recent work suggests that ceramide may also induce stem cell differentiation [35, 4143]. As a cautionary note, however, one should distinguish between the effect of endogenous and exogenously added ceramide, in particular when using short-chain ceramide such as C2 ceramide. A comprehensive analysis of endogenous ceramide species during stem cell differentiation has shown that consistent with vast changes in the expression of different ceramide synthase isoforms, the proportion of C18, C24, and C24:1 ceramide increases while that of C16 ceramide decreases when undifferentiated ES cells mature to embryoid bodies [44].

Despite this translational outcome of our work showing a method to eliminate tumor stem cells via PAR-4 as a sensitizer to ceramide analogs, the physiological function of PAR-4 for neural development still remains unclear. At first, we were intrigued by the observation that PAR-4 is asymmetrically distributed during cell division of neural progenitors. We found that the PAR-4 inheriting (or expressing) daughter cell died, while the PAR-4 (-), nestin expressing daughter cell, survived and underwent further neuronal differentiation [35]. We thought that this would be a great way to eliminate half of the neural progenitor population as observed during mouse brain development. However, since the PAR-4 knockout mouse did not show a gross embryonic phenotype, we focused on PAR-4 as a protein that induces apoptosis if inappropriately expressed during embryonic or postnatal development. We found that the pathological expression of PAR-4 facilitates ceramide-induced apoptosis in two cell types: neural crest-derived cells and astrocytes.

Neural crest-derived cells are the precursors for many neural and nonneural cell types. They originate from the roof plate of the closing neural tube (neural crest) and proliferate and migrate extensively throughout the embryo. Among the tissues differentiated from neural crest-derived cells are the facial bones and many supportive cells (e.g., pericytes) of the central nervous system. This shared provenance of specific skeletal and brain tissues caught our attention when we were studying the effect of ethanol on apoptosis of neural progenitor cells. In fetal alcohol syndrome, a birth defect caused by maternal consumption of alcoholic beverages during pregnancy, facial malformation, and cognitive retardation are the most obvious and severe symptoms of the newborn. Therefore, we hypothesized that neural crest-derived progenitor cells are very sensitive to ethanol, which leads to malformation of neural crest-derived tissues in fetal alcohol syndrome. Our studies showed for the first time that ethanol elevates the expression of PAR-4 and ceramide in neural crest-derived tissue culture and embryos in vivo [45]. Elevation of PAR-4 leading to enhanced sensitivity toward ceramide was also found in primary cultured astrocytes generated from newborn pups that carry a mutation of presenilin 1 (Psen 1), a gene mutated in familial Alzheimer's disease [46]. Taken together, these results strongly suggest that the simultaneous elevation of PAR-4 and ceramide is involved in several pathological phenotypes showing tissue degeneration due to enhanced apoptosis.

About ten years ago, we began to investigate which cell-signaling pathway is downstream of the ceramide-aPKC apoptosis complex (CAP-AC), and what distinguishes the cell-signaling effect of this proapoptotic lipid-protein complex from that of the ceramide-aPKC-polarity complex (CAP-PC). Based on experimental evidence obtained with neuroblastoma cells and ES cell-derived neural progenitors, our very first model suggested that CAP-AC will reduce activation of Akt/PKB and MAPK/ERK2, which will lead to activation of Bad and reduced protein levels of Bcl-2 [36] (Figure 2(b)). Bad and Bcl-2 are two BH3-only proteins counterregulating apoptosis by either facilitating or preventing the release of cytochrome c from mitochondria. In follow-up studies, we found that CAP-AC also downregulates the transcription factor NF-κB, which is critical for neural progenitor cell survival [20] (Figure 2(b)). On the other hand, CAP-PC inactivated GSK-3β, a different cell-signaling pathway regulating the function of β-catenin [21] (Figures 2(b) and 3). Most recently, we published a model showing that the CAP-AC- and PC-induced cell-signaling pathways are at the cross roads of cell-signaling pathways for apoptosis and cell polarity [22].

Several studies have shown that aPKC phosphorylates Akt as well as GSK-3β, which coregulates cell survival and polarity [4749]. In cells with a low level of PAR-4 expression or activity; this pathway will be induced by ceramide. In cells with high level of PAR-4 expression or activity, however, this pathway is inhibited, eventually leading to apoptosis. Therefore, we hypothesize that apoptosis can be understood as a disorder of cell polarity, which may eliminate cells that do not polarize or else they would form dysfunctional or cancerous tissues.

It should be noted that other groups have also investigated the effect of ceramide on aPKC and Akt [5056]. Consistent with our results, one group found that the ceramide-aPKC interaction leads to inhibition of Akt [54, 57]. However, this group has attributed the inhibitory effect to ceramide-induced activation of aPKC. It is possible that the effect of ceramide on Akt may be modulated by aPKC-interacting proteins such as Par6 and PAR-4. Recent evidence in literature suggests that an aPKC-Par6 complex activates Akt, while an aPKC-PAR-4 complex inactivates this kinase [47, 58]. Whether aPKC activates or inactivates Akt may thus critically depend on where and with which other proteins ceramide-associated aPKC interacts. This compartmentalization of ceramide and aPKC will be discussed in the following and in the last section of this paper.

5. Is It Time to Define a Specific Ceramide Compartment, the “Sphingosome”?

The previous sections were concerned with the function of ceramide for individual aspects of cell polarity such as cell adhesion and migration. Most recently, we have found evidence that ceramide is involved in another phenomenon of polarized cells: ciliogenesis [24]. Non-dividing mammalian cells, regardless of residing within an epithelium or migrating, form a primary cilium. This cilium is studded with growth factor receptors, and it is assumed to act like an antenna or global positioning system, scanning the environment for sources of growth factors. When using our antibody against ceramide for immunocytochemistry with ciliated MDCK cells, we found that at the basis of the primary cilium, ceramide is highly enriched in a Golgi-derived compartment [24] (Figure 3(b)). Depletion of ceramide after establishment of cell adhesion and apicobasal polarity prevented ciliogenesis and obliterated the primary cilium. Addition of C16 ceramide or S18 to the medium restored or even enhanced ciliogenesis. Our study was the first evidence that ceramide is critical for formation or maintenance of the primary cilium.

It has been shown in previous studies that aPKC is critical for ciliogenesis [59, 60]. Therefore, we hypothesized that the ceramide-aPKC interaction is functionally involved in this process. Using immunocytochemistry, we found that the ceramide-enriched compartment at the basis of the primary cilium engulfed the centriole forming the basal body [24]. We also showed that the ceramide-enriched compartment was codistributed with the Golgi matrix protein GM130, a marker for cis Golgi. Most importantly, the ceramide-enriched compartment was codistributed with aPKC and Cdc42, indicating that that the core polarity complex consisting of aPKC-Par6-Cdc42 is associated with ceramide at the base of the cilium. At this point, we do not know if ceramide induces, recruits, or sustains this complex. We also do not know if ceramide is critical for the initial formation or other processes such as elongation of the primary cilium. However, it is clear from our studies that the compartmentalization of ceramide and therefore, localized formation of ceramide-associated protein complexes is instrumental in the regulation of cell polarity and ciliogenesis (Figure 3).

It should be noted that other groups have also found evidence for the ceramide-dependent compartmentalization of intracellular proteins. Yusuf Hannun's group has described a juxtanuclear recycling compartment termed “pericentrion” [61]. Formation of this compartment is induced by activation of PKCα/β2 with phorbol ester, and it is abolished by ceramide depletion with fumonisin B1. Although Hannun's group did not show ceramide enrichment in this compartment and found a different mechanism for the activity of ceramide (activation of PP2a leading to PKCα/β2-induced pericentrion sequestration), there are striking similarities to the apical ceramide-enriched compartment (ACEC) found in our group. It is also noteworthy that other sphingolipids have been implicated in the compartmentalization of polarized cells. Pioneering work in Kai Simmon's and Gerrit van Meer's groups demonstrated that glycosphingolipids and sphingomyelin are asymmetrically transported and distributed in polarized MDCK cells [62]. Of interest are also recent studies showing that the gangliosides GM3 and GM1 are differentially distributed to microvilli and primary cilia in polarized cells [63]. Taken together, there is growing evidence that sphingolipids, and in particular ceramide, may organize a specialized apical compartment in polarized cells. We suggest the term “sphingosome” for this compartment to include ceramide and other sphingolipids in its composition and generation (Figures 3(b) and 3(c)). We will now investigate how the sphingosome may be regulated by the distinct composition of sphingolipids and how it participates in the regulation of cell polarity and differentiation.


This study was supported by the March of Dimes Grant 6-FY08-322 and the NIH Grant R01AG034389. The author also acknowledges institutional support (under directorship of Dr. Lin Mei) at the Medical College of Georgia/Georgia Health Sciences University, Augusta, GA.

ACEC: Apical ceramide-enriched compartment
aPKC: Atypical PKC
CAP-AC: Ceramide-aPKC apoptosis complex
CAP-PC: Ceramide-aPKC polarity complex
MDCK: Madin-Darby Canine Kidney
PAR-4: Prostate apoptosis response 4
SLIPS: Sphingolipid-induced protein scaffold
S18: N-oleoyl serinol.

1. Okazaki T,Bell RM,Hannun YA. Sphingomyelin turnover induced by vitamin D in HL-60 cells. Role in cell differentiationJournal of Biological ChemistryYear: 19892643219076190802808413
2. Hannun YA,Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulationScienceYear: 198924348905005072643164
3. Jayadev S,Liu B,Bielawska AE,et al. Role for ceramide in cell cycle arrestJournal of Biological ChemistryYear: 19952705204720527836432
4. Bielawska A,Crane HM,Liotta D,Obeid LM,Hannun YA. Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramideJournal of Biological ChemistryYear: 19932683526226262328253743
5. Obeid LM,Linardic CM,Karolak LA,Hannun YA. Programmed cell death induced by ceramideScienceYear: 19932595102176917718456305
6. Kolesnick RN,Haimovitz-Friedman A,Fuks Z. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiationBiochemistry and Cell BiologyYear: 19947211-124714747544586
7. Desai K,Sullards MC,Allegood J,et al. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosisBiochimica et Biophysica ActaYear: 200215852-318819212531553
8. Marasas WFO,Riley RT,Hendricks KA,et al. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maizeJournal of NutritionYear: 2004134471171615051815
9. Fujita T,Inoue K,Yamamoto S,et al. Fungal metabolites—part 11: a potent immunosuppressive activity found in Isaria sinclairii metaboliteJournal of AntibioticsYear: 19944722082158150717
10. Hanada K,Nishijima M,Fujita T,Kobayashi S. Specificity of inhibitors of serine palmitoyltransferase (SPT), a key enzyme in sphingolipid biosynthesis, in intact cells. A novel evaluation system using an SPT-defective mammalian cell mutantBiochemical PharmacologyYear: 200059101211121610736421
11. Miyake Y,Kozutsumi Y,Nakamura S,Fujita T,Kawasaki T. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocinBiochemical and Biophysical Research CommunicationsYear: 199521123964037794249
12. Merrill AH Jr.,Schmelz EM,Dillehay DL,et al. Sphingolipids—the enigmatic lipid class: biochemistry, physiology and pathophysiologyToxicology and Applied PharmacologyYear: 199714212082259007051
13. Ogretmen B,Pettus BJ,Rossi MJ,et al. Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramideJournal of Biological ChemistryYear: 200227715129601296911815611
14. Kitatani K,Idkowiak-Baldys J,Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signalingCellular SignallingYear: 20082061010101818191382
15. Sultan I,Senkal CE,Ponnusamy S,et al. Regulation of the sphingosine-recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-Myc/Max functionBiochemical JournalYear: 2006393251352116201965
16. Krishnamurthy K,Wang G,Silva J,Condie BG,Bieberich E. Ceramide regulates atypical PKCζ/λ-mediated cell polarity in primitive ectoderm cells: a novel function of sphingolipids in morphogenesisJournal of Biological ChemistryYear: 200728253379339017105725
17. Wang G,Krishnamurthy K,Chiang YW,Dasgupta S,Bieberich E. Regulation of neural progenitor cell motility by ceramide and potential implications for mouse brain developmentJournal of NeurochemistryYear: 2008106271873318466329
18. Bieberich E,Hu B,Silva J,et al. Synthesis and characterization of novel ceramide analogs for induction of apoptosis in human cancer cellsCancer LettersYear: 20021811556412430179
19. Bieberich E,Kawaguchi T,Yu RK. N-acylated serinol is a novel ceramide mimic inducing apoptosis in neuroblastoma cellsJournal of Biological ChemistryYear: 2000275117718110617602
20. Wang G,Silva J,Krishnamurthy K,Tran E,Condie BG,Bieberich E. Direct binding to ceramide activates protein kinase Cζ before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cellsJournal of Biological ChemistryYear: 200528028264152642415901738
21. Wang G,Krishnamurthy K,Umapathy NS,Verin AD,Bieberich E. The carboxyl-terminal domain of atypical protein kinase Cζ binds to ceramide and regulates junction formation in Epithelial cellsJournal of Biological ChemistryYear: 200928421144691447519304661
22. Bieberich E. Ceramide signaling in cancer and stem cellsFuture LipidologyYear: 20083327330019050750
23. Krishnamurthy K,Dasgupta S,Bieberich E. Development and characterization of a novel anti-ceramide antibodyJournal of Lipid ResearchYear: 200748496897517210985
24. Wang G,Krishnamurthy K,Bieberich E. Regulation of primary cilia formation by ceramideJournal of Lipid ResearchYear: 200950102103211019372594
25. Mukhopadhyay A,Saddoughi SA,Song P,et al. Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signalingFASEB JournalYear: 200923375176319028839
26. Houssa B,van Blitterswijk WJ. Specificity of cysteine-rich domains in diacylglycerol kinases and protein kinases CThe Biochemical JournalYear: 1998331, part 26776799531512
27. van Blitterswijk WJ. Hypothesis: ceramide conditionally activates atypical protein kinases C, Raf-1 and KSR through binding to their cysteine-rich domainsThe Biochemical JournalYear: 1998331, part 26796809531568
28. Yin X,Zafrullah M,Lee H,Haimovitz-Friedman A,Fuks Z,Kolesnick R. A ceramide-binding C1 domain mediates kinase suppressor of Ras membrane translocationCellular Physiology and BiochemistryYear: 2009243-421923019710537
29. Moser AR,Shoemaker AR,Connelly CS,et al. Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulationDevelopmental DynamicsYear: 199520344224337496034
30. Pewzner-Jung Y,Brenner O,Braun S,et al. A critical role for ceramide synthase 2 in liver homeostasis II. Insights into molecular changes leading to hepatopathyJournal of Biological ChemistryYear: 201028514109111092320110366
31. Pewzner-Jung Y,Park H,Laviad EL,et al. A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathwaysJournal of Biological ChemistryYear: 201028514109021091020110363
32. Imgrund S,Hartmann D,Farwanah H,et al. Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomasJournal of Biological ChemistryYear: 200928448335493356019801672
33. Spassieva S,Hille J. Plant sphingolipids today—are they still enigmatic?Plant BiologyYear: 200352125136
34. Bieberich E. Smart drugs for smarter stem cells: making SENSe (sphingolipid-enhanced neural stem cells) of ceramideNeuroSignalsYear: 2008162-312413918253053
35. Bieberich E,MacKinnon S,Silva J,Noggle S,Condie BG. Regulation of cell death in mitotic neural progenitor cells by asymmetric distribution of prostate apoptosis response 4 (PAR-4) and simultaneous elevation of endogenous ceramideJournal of Cell BiologyYear: 2003162346947912885759
36. Bieberich E,MacKinnon S,Silva J,Yu RK. Regulation of apoptosis during neuronal differentiation by ceramide and b-series complex gangliosidesJournal of Biological ChemistryYear: 200127648443964440411574545
37. Bieberich E,Silva J,Wang G,Krishnamurthy K,Condie BG. Selective apoptosis of pluripotent mouse and human stem cell by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplantsJournal of Cell BiologyYear: 2004167472373415545317
38. Wang G,Silva J,Krishnamurthy K,Bieberich E. A novel isoform of prostate apoptosis response 4 (PAR-4) that co-distributes with F-actin and prevents apoptosis in neural stem cellsApoptosisYear: 200611331532516520897
39. Díaz-Meco MT,Municio MM,Frutos S,et al. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase CCellYear: 19968657777868797824
40. Moscat J,Diaz-Meco MT. The atypical protein kinase Cs: functional specificity mediated by specific protein adaptersEMBO ReportsYear: 20001539940311258478
41. Salli U,Fox TE,Carkaci-Salli N,et al. Propagation of undifferentiated human embryonic stem cells with nano-liposomal ceramideStem Cells and DevelopmentYear: 2009181556618393629
42. Herget T,Esdar C,Oehrlein SA,et al. Production of ceramides causes apoptosis during early neural differentiation in vitroJournal of Biological ChemistryYear: 200027539303443035410862608
43. Yoon BS,Jun EK,Park G,et al. Optimal suppression of protein phosphatase 2A activity is critical for maintenance of human embryonic stem cell self-renewalStem CellsYear: 201028587488420306465
44. Park H,Haynes CA,Nairn AV,et al. Transcript profiling and lipidomic analysis of ceramide subspecies in mouse embryonic stem cells and embryoid bodiesJournal of Lipid ResearchYear: 201051348048919786568
45. Wang G,Bieberich E. Prenatal alcohol exposure triggers ceramide-induced apoptosis in neural crest-derived tissues concurrent with defective cranial developmentCell Death and DiseaseYear: 20101, article e46
46. Wang G,Silva J,Dasgupta S,Bieberich E. Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytesGliaYear: 200856444945618205190
47. Weyrich P,Neuscheler D,Melzer M,Hennige AM,Häring HU,Lammers R. The Par6α/aPKC complex regulates Akt1 activity by phosphorylating Thr34 in the PH-domainMolecular and Cellular EndocrinologyYear: 20072681-2303617335965
48. Kim M,Datta A,Brakeman P,Yu W,Mostov KE. Polarity proteins PAR6 and aPKC regulate cell death through GSK-3β in 3D epithelial morphogenesisJournal of Cell ScienceYear: 2007120142309231717606986
49. Etienne-Manneville S,Hall A. Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarityNatureYear: 2003421692475375612610628
50. Zhou H,Summers SA,Birnbaum MJ,Pittman RN. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosisJournal of Biological ChemistryYear: 19982732616568165759632728
51. Navarro P,Valverde AM,Rohn JL,Benito M,Lorenzo M. Akt mediates insulin rescue from apoptosis in brown adipocytes: effect of ceramideGrowth Hormone and IGF ResearchYear: 200010525626611042022
52. Powell DJ,Hajduch E,Kular G,Hundal HS. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanismMolecular and Cellular BiologyYear: 200323217794780814560023
53. Ji EO,Kwang SS,Se JL,Mie YK. Induction of apoptotic cell death by a ceramide analog in PC-3 prostate cancer cellsArchives of Pharmacal ResearchYear: 200629121140114617225464
54. Fox TE,Houck KL,O’Neill SM,et al. Ceramide recruits and activates protein kinase Cζ (PKCζ) within structured membrane microdomainsJournal of Biological ChemistryYear: 200728217124501245717308302
55. Arboleda G,Morales LC,Benítez B,Arboleda H. Regulation of ceramide-induced neuronal death: cell metabolism meets neurodegenerationBrain Research ReviewsYear: 200959233334618996148
56. Bourbon NA,Yun J,Kester M. Ceramide directly activates protein kinase Cζ to regulate a stress-activated protein kinase signaling complexJournal of Biological ChemistryYear: 200027545356173562310962008
57. Bourbon NA,Sandirasegarane L,Kester M. Ceramide-induced inhibition of Akt is mediated through protein kinase Cζ. Implications for growth arrestJournal of Biological ChemistryYear: 200227753286329211723139
58. Joshi J,Fernandez-Marcos PJ,Galvez A,et al. Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesisEMBO JournalYear: 200827162181219318650932
59. Sfakianos J,Togawa A,Maday S,et al. Par3 functions in the biogenesis of the primary cilium in polarized epithelial cellsJournal of Cell BiologyYear: 200717961133114018070914
60. Ossipova O,Tabler J,Green JBA,Sokol SY. PAR1 specifies ciliated cells in vertebrate ectoderm downstream of aPKCDevelopmentYear: 2007134234297430617993468
61. Kitatani K,Idkowiak-Baldys J,Hannun YA. Mechanism of inhibition of sequestration of protein kinase C alpha/betaII by ceramide. Roles of ceramide-activated protein phosphatases and phosphorylation/dephosphorylation of protein kinase C alpha/betaII on threonine 638/641Journal of Biological ChemistryYear: 200728228206472065617504762
62. van Meer G,Stelzer EH,Wijnaendts-van-Resandt RW,Simons K. Sorting of sphingolipids in epithelial (Madin-Darby canine kidney) cellsJournal of Cell BiologyYear: 19871054162316353667693
63. Janich P,Corbeil D. GM and GM gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cellsFEBS LettersYear: 200758191783178717428477

Article Categories:
  • Review Article

Previous Document:  Apoptotic sphingolipid ceramide in cancer therapy.
Next Document:  Regulation of Serum Response Factor and Adiponectin by PPAR? Agonist Docosahexaenoic Acid.